首页> 外文期刊>Journal of chromatography, B. Analytical technologies in the biomedical and life sciences >Sensitive and accurate analyses of free 3-nitrotyrosine in exhaled breath condensate by LC-MS/MS
【24h】

Sensitive and accurate analyses of free 3-nitrotyrosine in exhaled breath condensate by LC-MS/MS

机译:LC-MS / MS灵敏而准确地分析呼出气冷凝物中的游离3-硝基酪氨酸

获取原文
获取原文并翻译 | 示例
       

摘要

The quantitative determination of 3-nitro-L-tyrosine, a biological marker for inflammatory processes, in exhaled breath condensate (EBC) is described. The clean-up and preconcentration was performed by solid phase extraction (SPE). After liquid chromatography the specific detection was performed by tandem mass spectrometry using electron spray ionisation and selected reaction monitoring (SRM). C-13(9)-3-nitrotyrosine was used as an internal standard. For reliability, tests for the precision of the method, the losses during preparation, a test for nitrating artifacts and the comparibility of calibrants in EBC and buffer solution were performed. The calibration of the method was linear over a range of 10-500 pg/mL. The within-run coefficients of variation (CV) of the samples were found to be 8.4% at 25 pg/mL and 8.3% at 250 pg/mL. The day-to-day CV was found to be 11.2%. The limit of quantification was 3.9 pg/mL. The losses during preparation were 15%. The discrepancy between the calibration with EBC and buffer solution was below 10%. No artificial production of 3-nitrotyrosine was observed during the procedure. The application of the method on the EBC samples of healthy smokers (N= 10) and non-smokers (N= 10) showed no difference between the two groups. The concentration of 3-nitrotyrosine ranged between the limit of quantification and 184 pg/mL and was distinctly lower than data detected by an immunoassay procedure. The procedure was proven to be accurate, sensitive and in contrast to GC methods less elaborate and is recommended for the determination of 3-nitrotyrosine in exhaled breath condensate. (c) 2005 Elsevier B.V. All rights reserved.
机译:描述了呼出气冷凝物(EBC)中炎性过程的生物标志物3-硝基-L-酪氨酸的定量测定。净化和预浓缩通过固相萃取(SPE)进行。液相色谱后,通过串联质谱使用电子喷雾电离和选择的反应监测(SRM)进行特异性检测。 C-13(9)-3-硝基酪氨酸用作内标。为了可靠性,进行了方法精度,制备过程中的损失,硝化伪影测试以及EBC和缓冲液中校准物的可比性测试。该方法的校准在10-500 pg / mL范围内是线性的。发现样品的批内变异系数(CV)在25 pg / mL时为8.4%,在250 pg / mL时为8.3%。发现日常CV为11.2%。定量限为3.9 pg / mL。准备期间的损失为15%。用EBC校准和缓冲溶液之间的差异低于10%。在该过程中未观察到人工产生的3-硝基酪氨酸。该方法在健康吸烟者(N = 10)和非吸烟者(N = 10)的EBC样品上的应用显示两组之间没有差异。 3-硝基酪氨酸的浓度介于定量限和184 pg / mL之间,明显低于免疫分析程序检测到的数据。与GC方法相比,该方法被证明是准确,灵敏的,并且操作复杂度较低,建议用于呼出气冷凝物中的3-硝基酪氨酸的测定。 (c)2005 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号